Acquirer | Target | Price |
---|---|---|
OptumRx | AlexaCare Holdings, Inc. | N/A |
Charles River Laboratories | Oncotest GmbH | $36 million |
CONMED Corporation | SuriQuest, Inc. | $265 million |
ams AG | CMOSIS | $235 million |
Depomed Inc. | Depomed Inc. Rights to cebranopadol | N/A |
Acquirer | Target | Price |
---|---|---|
OptumRx | AlexaCare Holdings, Inc. | N/A |
Charles River Laboratories | Oncotest GmbH | $36 million |
CONMED Corporation | SuriQuest, Inc. | $265 million |
ams AG | CMOSIS | $235 million |
Depomed Inc. | Depomed Inc. Rights to cebranopadol | N/A |